Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,759 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07670468RecruitingPhase 1/Phase 2
T-cell therapy for resistant viral infections after transplant or cancer treatment
This trial tests a special T-cell treatment (LB-DTK-MV) for people with virus infections (CMV, BKV, EBV) that did not get better with standard medicines. It is for patients who had a stem cell transplant or certain cancer therapies like CAR-T or bispecific antibodies.
SeoulAges 19 years+ - NCT07485686Enrolling by invitation
Studying urinary tract infections to improve treatment
This study collects medical data from people with urinary tract infections (UTIs) to help future research and improve how UTIs are treated. You may be eligible if you have symptoms of a UTI now or have had them in the past.
FrankfurtAges 18 years+ - NCT07107555Enrolling by invitation
Study of severe tissue infections
This trial studies a rare but serious infection called necrotizing soft-tissue infection (NSTI), which destroys tissue quickly. It looks at how patients are treated in hospitals across Europe to improve care.
BarcelonaAges 18 years+ - NCT06736691Enrolling by invitationPhase 3
Testing a new deworming drug for whipworm
This trial is testing a new deworming drug called emodepside for people with whipworm infections. It aims to see if emodepside is safe and effective at clearing the infection.
Chake ChakeAges 12 years+ - NCT06857071Recruiting
Using social networks to find undiagnosed HIV cases
This study tests whether asking people with a new HIV diagnosis to invite their friends and contacts for testing can find more undiagnosed cases and reduce stigma. If you or someone you know was recently diagnosed with HIV in the Msunduzi area, this could help connect more people to care.
Pietermaritzburg, KwaZulu-NatalAges 18 years+ - NCT06771050RecruitingPhase 4
Antibiotics and surgery for hip and knee joint infections
This trial tests different antibiotic types and durations, plus surgical approaches, for people with a current joint infection in a hip or knee. It aims to find the best way to treat the infection and prevent it from coming back.
Garran, Australian Capital TerritoryAges 18 years+ - NCT04724603Recruiting
Review of side effects after phage treatment for bone infections
This study looks back at people who were treated with phage therapy for a bone, joint, or implant infection and later had a side effect. It aims to better understand how safe phage therapy is in real-life use.
LyonAges Any age - NCT05000723Recruiting
Follow-up for hip joint infection after joint replacement
This study checks what happens over the long term for people who had an infection around a replaced (prosthetic) hip. It mainly helps doctors understand recovery and long-term outcomes after treatment.
LeuvenAges 18 years+ - NCT00796263RecruitingPhase 3
Test HIV medicines for people with new or long-term HIV
This Phase 3 study looks at antiretroviral treatment (HIV medicines) for adults with either recent (acute) or long-term (chronic) HIV. It’s designed to see how well and safely ongoing HIV treatment works, and it may help you get structured care and monitoring.
BangkokAges 18 years+ - NCT02271243Recruiting
Find the source of bloodstream infections from central line germs
This study uses special genetic testing of bacteria from blood to figure out where central-line bloodstream infections come from. Results may help doctors better identify the source and improve prevention and treatment.
Boston, MassachusettsAges Any age - NCT05071079Recruiting
Study infects volunteers with a malaria germ to test treatment
This study gives healthy volunteers a controlled infection with a type of malaria (vivax) to see how the infection behaves and how well curative anti-malaria medicine works. It may help researchers better design and test future malaria vaccines and treatments.
BangkokAges 20–55 - NCT06711575Recruiting
Personalized antibiotics for spinal infections
This trial is studying how to personalize the dose of anti-infection drugs for people with spinal infections. The goal is to find the best treatment for each patient to improve outcomes and reduce side effects.
JinanAges Any age - NCT06711562Recruiting
Personalized Dosing for Bone and Joint Infection
This study aims to customize anti-infection medication doses for people with bone or joint infections. The goal is to make treatment more effective and reduce side effects.
JinanAges Any age - NCT07396428Recruiting
Reducing antibiotic use for respiratory infections in Swiss primary care
This study tests whether following a national guideline for treating common respiratory infections (like colds, sore throats, or bronchitis) can help doctors in Switzerland prescribe fewer antibiotics. It focuses on primary care physicians and clinics in certain cantons who are willing to participate in surveys and interviews.
Lausanne, Canton of VaudAges Any age - NCT07214311RecruitingPhase 2/Phase 3
A trial of PLG0206 to prevent knee joint infection after surgery
This trial tests if a new drug called PLG0206 can stop a knee joint infection from coming back after a surgery called DAIR. DAIR cleans the infected area and keeps the artificial knee in place, and this study wants to see if adding PLG0206 helps prevent the infection from returning.
Sarasota, FloridaAges 18–80 - NCT06828848RecruitingPhase 2
Study of Vaborem in children with Gram negative infections
This trial tests how Vaborem is absorbed and tolerated in children with serious bacterial infections, including complicated urinary tract infections. It aims to find the right dose for children.
OstravaAges birth–17 years - NCT06529159Recruiting
Treating H. pylori with argon plasma during endoscopy
This trial tests a new way to treat H. pylori infection using argon plasma (a kind of energy) during an upper endoscopy. It may help people who haven't yet taken antibiotics for H. pylori and are already having an endoscopy.
Boston, MassachusettsAges 18 years+ - NCT07261969Recruiting
Blood test and leaflet to guide antibiotic use for respiratory infections
This trial tests if a quick blood test (C-reactive protein, CRP) and a patient leaflet can help doctors prescribe antibiotics only when needed for adults with respiratory tract infections. It aims to reduce unnecessary antibiotic use.
Sokuluk Village, Chui RegionAges 18–70 - NCT07209917Recruiting
Cervical cancer prevention for women with HIV and HPV
This trial tests a new way to prevent cervical cancer in women with both HIV and HPV. It focuses on women in India who are already on stable HIV treatment and have a normal cervical exam.
Bangalore, KarnatakaAges 25–50 - NCT07239219Recruiting
Testing a special rinse to prevent infection after catheter removal
This trial tests whether using a special antiseptic solution (Irrisept) when removing a urinary catheter can lower the chance of getting a urinary tract infection. It is for people visiting a urology clinic for catheter removal who are not already on antibiotics.
Columbus, OhioAges 18 years+ - NCT06926894RecruitingPhase 1
A cell therapy for viral infections in children and young adults
This trial tests a special immune cell treatment (R-MVST cells) for children and young adults who have had a stem cell or organ transplant and are fighting stubborn viral infections like EBV, CMV, ADV, or BK virus. The goal is to see if these cells can help control the viruses when standard medicines haven't worked well enough.
New York, New YorkAges 3 months–26 years - NCT03704766Recruiting
Testing fluid markers to detect pediatric joint infections
This study checks special lab markers in joint fluid to tell septic (infected) arthritis apart from other inflammatory causes in children. It may help clinicians detect infection more accurately and quickly so kids can get the right treatment.
Atlanta, GeorgiaAges Up to 17 years - NCT05645107RecruitingPhase 3
XEMBIFY plus usual care to prevent infections
This Phase 3 study tests whether XEMBIFY (an immune protein therapy) plus standard medical treatment can better prevent serious or repeated infections. It is for people with certain cancers of blood/immune systems who are already having trouble with infections.
Huntington Park, CaliforniaAges 18 years+ - NCT05814432RecruitingPhase 3
High-dose antifungal for widespread Histoplasmosis in HIV
This Phase 3 trial tests whether a high-dose form of amphotericin B made in tiny fat particles (liposomal amphotericin B) is safer and more effective for treating widespread Histoplasmosis in adults with HIV. It may help people who have a serious, whole-body infection caused by Histoplasma.
Goiânia, GoiásAges 18 years+
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,759 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.